Our mission comes to life through the people who depend on our products to manage their heart health everyday. Cardiovascular disease remains the leading cause of death globally, and is responsible for more than $1 billion in annual healthcare spending. More importantly, it takes a tremendous toll on people’s lives and the lives of their caregivers, families, and friends.
Prevention is critical for reversing this trend and enabling people to live longer, healthier lives. Our FDA-cleared Kardia™ devices deliver clinical-quality ECGs capable of identifying some of the most common and dangerous irregular heart rhythms, including atrial fibrillation, Bradycardia, Tachycardia, Sinus Rhythm with PVCs, Sinus Rhythm with Wide QRS, and Sinus Rhythm with SVE. This places the power of advanced AI technology directly in our customers’ hands, giving them answers and peace of mind. Additionally, healthcare providers have a way to capture their patients’ arrhythmias, leading to earlier diagnosis and improving clinical decision-making.
Learn more about how we’re advancing the future of heart care to benefit people with cardiovascular disease and healthcare providers in the video above.
Early diagnosis means early treatment and, thanks to digital technology and AI, we’re able to make better and faster diagnoses. [KardiaMobile]accelerated definite therapy for me – I recommend it to my patients.
Dr. Cleveland Francis
Cardiologist and patient